MedPath

HMS CONCEPT N-MEPLUZ CAPSULE

Registration Number: MAL20086048N

Approved
Approval ID

159f6f5482ab614f

Registration Number

MAL20086048N

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types4 types
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (4)

30 CapsulesAvailable
Package Size: 30 Capsules
Status: NPRA Approved
60 CapsulesAvailable
Package Size: 60 Capsules
Status: NPRA Approved
90 CapsulesAvailable
Package Size: 90 Capsules
Status: NPRA Approved
120 CapsulesAvailable
Package Size: 120 Capsules
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (6)

BENFOTIAMINEActive
Monograph: 苯磷硫胺
ALPHA LIPOIC ACIDActive
Monograph: 硫辛酸
INOSITOLActive
Monograph: 肌醇
METHYLCOBALAMINActive
Monograph: 甲钴胺
CHROMIUM POLYNICOTINATEActive
Monograph: chromium polynicotinate
PYRIDOXINE HYDROCHLORIDEActive
Monograph: 维生素B6

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

HMS CONCEPT N-MEPLUZ CAPSULE - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform